Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis

Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo

(2015) Hidemasa Katsumi et al.   PLoS One

Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy

(2014) Silvia Peppicelli et al.   CANCER AND METASTASIS REVIEWS

Experimental Anticancer Therapy with Vascular-disruptive Peptide and Liposome-entrapped Chemotherapeutic Agent

(2010) Aleksander Sochanik et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery

(2010) Thommey P. Thomas et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats

(2010) Zhengqi Dong et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery

(2010) Gemma Navarro et al.   JOURNAL OF CONTROLLED RELEASE

Design, synthesis, and biological evaluation of novel estradiol–bisphosphonate conjugates as bone-specific estrogens

(2009) Masahiko Morioka et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil

(2008) Tsutomu Mizoshita et al.   International Journal of Clinical Oncology